MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Marketable securities,current$290,109K Cash and cashequivalents$46,935K Prepaid expenses andother current assets$6,813K Total current assets$343,857K Marketable securities,long-term$142,539K Operating leaseright-of-use assets$1,830K Property and equipment,net$288K Other non-currentassets$103K Total assets$488,617K Total liabilities andstockholders equity$488,617K Total stockholdersequity$471,930K Total liabilities$16,687K Accumulated deficit-$189,157K Additional paid-in capital$657,561K Total currentliabilities$15,374K Operating leaseliability, non-current$1,313K Series b non-votingconvertible preferred...$2,931K Accumulated othercomprehensive income (loss)$546K Common stock, 0.001 parvalue as of december...$49K Accrued expenses andother current...$10,591K Accounts payable$4,155K Operating leaseliability, current$619K Related party accountspayable and other...$9K
Balance Sheet
source: myfinsight.com

Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics, Inc. (ORKA)